Literature DB >> 15621838

Primary non-Hodgkin's lymphoma arising in an intramammary lymph node.

Ioannis D Venizelos1, Zoi A Tatsiou, Sofia Vakalopoulou, Eudokia Mandala, Vasiliki Garipidou.   

Abstract

Non-Hodgkin's lymphoma (NHL) of the breast may be primary or secondary. Both are rare and there are no morphological criteria to make the differential diagnosis. Benign intramammary lymph nodes are often encountered, but the development of either primary or secondary lymphoma within an intramammary lymph node is extremely rare. We report the case of a 72-year-old woman who presented with a palpable mass in her right breast. A mammography showed a large intramammary lymph node from which a biopsy was taken. On morphological and immunohistochemical examination the tumor fulfilled the criteria of NHL originating in an intramammary lymph node. The patient received chemotherapy which led to the disappearance of the mass. A review of the literature revealed that this is the third reported case of primary NHL originating in an intramammary lymph node.

Entities:  

Mesh:

Year:  2005        PMID: 15621838     DOI: 10.1080/10428190400015717

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer--a case report.

Authors:  Florian Rudolf Fritzsche; Stefan Pahl; Iver Petersen; Mick Burkhardt; Anja Dankof; Manfred Dietel; Glen Kristiansen
Journal:  Virchows Arch       Date:  2006-09-16       Impact factor: 4.064

2.  Primary Breast T Cell Lymphoma Involving Nipple-Areolar Complex in a Young Patient.

Authors:  Mithun Ram; Pooja Ramakant; Harshad Parmar; Biju George; M J Paul
Journal:  Indian J Surg       Date:  2016-01-25       Impact factor: 0.656

3.  Case of Primary Breast and Ipsilateral Axillary T-Cell Lymphoma: a Rare Occurrence.

Authors:  Faryal Afridi; Garry D Ruben; Eric Oristian
Journal:  Case Rep Surg       Date:  2020-09-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.